Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 72303-0830

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 72303-0830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hec Pharm Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg (Container Label 10mg)

Label of Rosuvastatin calcium 10 mg film-coated tablets by HEC Pharm USA Inc. The label shows the product name, strength (10 mg), dosage form (tablets), package size (90 tablets), and includes a barcode and storage instructions. Manufactured by Sunshine Lake Pharma Co., Ltd., China. Rx only.*

FDA Label Image

20mg (Container Label 20mg)

Label for Rosuvastatin Tablets USP, 20 mg film-coated oral tablets, packaged as 90 tablets. Distributed by HEC Pharm USA Inc., manufactured by Sunshine Lake Pharma Co., Ltd. Storage instructions include controlled room temperature and moisture protection. The label shows NDC 72303-0829-1 and a barcode.*

FDA Label Image

40mg (Container Label 40mg)

Label for Rosuvastatin calcium 40 mg film-coated tablets by HEC Pharm USA Inc. The label states the product contains 40 mg rosuvastatin per tablet, includes storage and usage warnings, and indicates 30 tablets per bottle. Manufactured by Sunshine Lake Pharma Co., Ltd. in Guangdong Province, China. The label features a barcode and revision date of 07/2026.*

FDA Label Image

5mg (Container Label 5mg)

Label for Rosuvastatin Tablets USP 5 mg film-coated tablets, distributed by HEC Pharm USA Inc. The bottle contains 90 tablets. The label includes storage instructions, a barcode, and indicates Rx only status. Manufactured by Sunshine Lake Pharma Co., Ltd., Guangdong Province, China. NDC 72303-0827-1.*

FDA Label Image

Figure_1_time_jupiter (Figure 1 Time Jupiter)

A cumulative incidence curve chart showing the comparison between Placebo and Rosuva (Rosuvastatin calcium) over a period of up to 6 years. The y-axis represents the cumulative incidence percentage, while the x-axis represents years. The chart includes hazard ratio (HR 0.56 with 95% confidence interval 0.46-0.69) and a p-value (<0.001), indicating statistical analysis of the data. A table below denotes the number at risk for RSV and Placebo groups at various time points.*

FDA Label Image

Figure_2-major_jupiter (Figure 2 Major Jupiter)

A data table comparing events between Rosuvastatin calcium 20 mg and placebo 20 mg groups, listing event counts, rates per 1000 patient-years, hazard ratios with 95% confidence intervals, and P values for several cardiovascular-related endpoints, including primary endpoint, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction (MI), hospitalized unstable angina, and arterial revascularization. The table includes a forest plot of hazard ratios with confidence intervals on the right.*

FDA Label Image

Figure_3_percent_dyslipidemia (Figure 3 Percent Dyslipidemia)

A box plot comparing percent change from baseline in LDL-C levels for four drugs at various doses: Rosuvastatin (Crestor) at 10, 20, and 40 mg; Atorvastatin at 10, 20, 40, and 80 mg; Simvastatin at 10, 20, 40, and 80 mg; and Pravastatin at 10, 20, and 40 mg. The y-axis shows percent change ranging approximately from 0 to -75.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Logo3 (Logo3)

FDA Label Image

Logo4 (Logo4)

FDA Label Image

Structural_formula (Structural Formula)

Chemical structure of rosuvastatin calcium, showing the molecular arrangement including aromatic rings, hydroxyl groups, sulfonyl, and calcium ion components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.